U.S. Department of Health and Human Services — National Institutes of Health

Crystal structure of dopa decarboxylase in complex with the inhibitor carbidopa

Autogenerated by

for

James Tyrwhitt Drake

Created on Mon, 2016-03-07 10:36, last updated on Mon, 2016-03-07 10:36

I Printed This

Remix It

Vertical Tabs

General Information

This Model was autogenerated from the "Quick Submit" tool.

Model ID

3DPX-002995

Category

Proteins, Macromolecules and Viruses

Keyword(s)

DOPA decarboxylase, carbiDOPA, Parkinson's disease, Vitamin B6, LYASE

Protein Data Bank ID

Experimental Method

X-RAY DIFFRACTION

Resolution

2.25

Model Details

Associated Species

Escherichia coli

Oligomeric Details

dimeric

R-Factor

0.144

Scattering Type

x-ray

Attribution

PubMed ID

Digital Object Identifier (DOI)

10.1038/nsb1101-963

Citation Title

Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.

Citation Year

2001

STL/VRML Files

PDB-1JS3-ribbon-secondary.wrl

PDB-1JS3-ribbon-rainbow.wrl

PDB-1JS3-ribbon-bychain.wrl

PDB-1JS3-ribbon.stl

PDB-1JS3-ribbon-thick.stl

PDB-1JS3-surf-bychain.wrl

PDB-1JS3-surf-hydropathy.wrl

PDB-1JS3-surf-coulombic.wrl

PDB-1JS3-surf.stl

X3D Files

PDB-1JS3-ribbon-secondary.x3d

PDB-1JS3-ribbon-rainbow.x3d

PDB-1JS3-ribbon-bychain.x3d

PDB-1JS3-ribbon.x3d

PDB-1JS3-ribbon-thick.x3d

PDB-1JS3-surf-bychain.x3d

PDB-1JS3-surf-hydropathy.x3d

PDB-1JS3-surf-coulombic.x3d

PDB-1JS3-surf.x3d

Blender Files

PDB-1JS3-ribbon-secondary.blend

PDB-1JS3-ribbon-rainbow.blend

PDB-1JS3-ribbon-bychain.blend

PDB-1JS3-ribbon.blend

PDB-1JS3-ribbon-thick.blend

PDB-1JS3-surf-bychain.blend

PDB-1JS3-surf-hydropathy.blend

PDB-1JS3-surf-coulombic.blend

PDB-1JS3-surf.blend

PDB-1JS3-ribbon-secondary.x3d

PDB-1JS3-ribbon-rainbow.x3d

PDB-1JS3-ribbon-bychain.x3d

PDB-1JS3-ribbon.x3d

PDB-1JS3-ribbon-thick.x3d

PDB-1JS3-surf-bychain.x3d

PDB-1JS3-surf-hydropathy.x3d

PDB-1JS3-surf-coulombic.x3d

PDB-1JS3-surf.x3d

QR Code for https://3dprint.nih.gov/discover/3dpx-002995

Rating

Licensing

Comments

0